1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Primary outcome in intent-to-treat analysis
Intent-to-treat analysis 1-year outcomeaCA 
(n = 111)		SAC 
(n = 94)
Treatment failure (composite) (No.) (%)30 (27.3)28 (30.1)
 Clinical
  mRS 62 (1.8)3 (3.2)
  mRS 3–53 (2.7)3 (3.2)
  Intracranial hemorrhage00
  Retreatment03 (3.2)
 Angiographic
  Immediate failure3 (2.7)1 (1.1)
  Residual aneurysm (core lab)22 (19.8)18 (19.4)
 Missing primary outcome1 (0.9)1 (1.1)
  • ↵a RR = 1.10; 95% CI, 0.71–1.71; P = .656.